2007
DOI: 10.1523/jneurosci.5047-06.2007
|View full text |Cite|
|
Sign up to set email alerts
|

Connecting TNF-α Signaling Pathways to iNOS Expression in a Mouse Model of Alzheimer's Disease: Relevance for the Behavioral and Synaptic Deficits Induced by Amyloid β Protein

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

13
179
0
2

Year Published

2008
2008
2020
2020

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 267 publications
(195 citation statements)
references
References 47 publications
13
179
0
2
Order By: Relevance
“…Similar findings have been reported for IL6, recently shown to directly modulate Tau phosphorylation via the cdk5/p35 pathway in hippocampal neurons (Quintanilla et al, 2004). TNFα has also been shown to directly induce the production of Aβ peptides in vitro (Yamamoto et al, 2007) and mediate amyloid-induced toxicity both in vitro and in vivo (Li et al, 2004;Medeiros et al, 2007). Moreover, inhibition of TNF receptor signaling in transgenic AD mice results in decreased Aβ plaque formation .…”
Section: Reelin-mediated Signaling In Normal and Pathological Aging: supporting
confidence: 82%
“…Similar findings have been reported for IL6, recently shown to directly modulate Tau phosphorylation via the cdk5/p35 pathway in hippocampal neurons (Quintanilla et al, 2004). TNFα has also been shown to directly induce the production of Aβ peptides in vitro (Yamamoto et al, 2007) and mediate amyloid-induced toxicity both in vitro and in vivo (Li et al, 2004;Medeiros et al, 2007). Moreover, inhibition of TNF receptor signaling in transgenic AD mice results in decreased Aβ plaque formation .…”
Section: Reelin-mediated Signaling In Normal and Pathological Aging: supporting
confidence: 82%
“…This contrasts previous reports where continuous peripheral TNF-a antagonism in RA patients improved cognition (Chen et al, 2010), suggesting that chronic rather than a single dose administration is needed to achieve such effects. However, it should be noted that Tobinick et al (2006) and Tobinick and Gross, (2008) observed a rapid improvement in cognition in a small cohort of patients with Alzheimer's disease (AD) following a single dose of peri-spinal etanercept and was supported by animal research on AD models where antagonism of TNF-a by ICV injection had immediate effects on cognition (Medeiros et al, 2007). Additionally, these findings suggest that centrally administered etanercept is more effective in attenuating cognitive impairment in CNS disease models such as AD, which are associated with more substantial cognitive deficits, than in our peripheral inflammatory model induced with a single dose of LPS.…”
Section: Discussionmentioning
confidence: 98%
“…IL-1b and TNF-a increase the level of iNOS mRNA by transcriptional activation [23]. These cytokines also increase the expression of COX-2, the activity of which is controlled by NOS, particularly by its inducible form [24].…”
Section: Introductionmentioning
confidence: 99%